KDIGO Individual Optimization of Management of CKD Patients with Diabetes and CVD Comorbidities

freecme000
Published on Feb 18, 2022
VIDEO EMBED ORIGINAL SOURCE - KDIGO
https://www.youtube.com/c/KDIGO/featured
Join KDIGO in a discussion about individual optimization of management of CKD patients with diabetes and CVD comorbidities. Prof. Christoph Wanner and a multi-disciplinary panel of international experts explore new cardio‐kidney protection therapies, such as SGLT2is and the glucagon-like receptor-1 agonists, and highlight why the relationship among cardiology, nephrology, and metabolic medicine is more important than ever.

This session was presented at the ISN World Congress of Nephrology 2021 - © International Society of Nephrology 2021. Supported by Boehringer Ingelheim Lilly.